MX378378B - Solucion acuosa cristaloide isotonica - Google Patents

Solucion acuosa cristaloide isotonica

Info

Publication number
MX378378B
MX378378B MX2019001077A MX2019001077A MX378378B MX 378378 B MX378378 B MX 378378B MX 2019001077 A MX2019001077 A MX 2019001077A MX 2019001077 A MX2019001077 A MX 2019001077A MX 378378 B MX378378 B MX 378378B
Authority
MX
Mexico
Prior art keywords
aqueous solution
sup
isotonic crystalloid
crystalloid aqueous
isotonic
Prior art date
Application number
MX2019001077A
Other languages
English (en)
Other versions
MX2019001077A (es
Inventor
Aryeh Shander
Duque Lara Oller
Original Assignee
Duque Lara Oller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59363165&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX378378(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Duque Lara Oller filed Critical Duque Lara Oller
Publication of MX2019001077A publication Critical patent/MX2019001077A/es
Publication of MX378378B publication Critical patent/MX378378B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/241—Lead; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención se refiere a una solución acuosa cristaloide isotónica del tipo que contiene Na+, K+ y Cl- y al uso de la misma como un vasodilatador.
MX2019001077A 2016-07-26 2017-07-18 Solucion acuosa cristaloide isotonica MX378378B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201631021A ES2651717B1 (es) 2016-07-26 2016-07-26 Solución acuosa cristaloide isotónica
PCT/EP2017/068141 WO2018019663A1 (en) 2016-07-26 2017-07-18 Isotonic crystalloid aqueous solution

Publications (2)

Publication Number Publication Date
MX2019001077A MX2019001077A (es) 2019-08-29
MX378378B true MX378378B (es) 2025-03-10

Family

ID=59363165

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019001077A MX378378B (es) 2016-07-26 2017-07-18 Solucion acuosa cristaloide isotonica

Country Status (17)

Country Link
US (1) US11426427B2 (es)
EP (1) EP3490526B1 (es)
JP (1) JP6976326B2 (es)
KR (1) KR102404536B1 (es)
CN (1) CN109789087B (es)
AU (1) AU2017304376A1 (es)
BR (1) BR112019001621A2 (es)
CA (1) CA3031845A1 (es)
DK (1) DK3490526T3 (es)
ES (2) ES2651717B1 (es)
HU (1) HUE051026T2 (es)
MX (1) MX378378B (es)
PL (1) PL3490526T3 (es)
PT (1) PT3490526T (es)
RU (1) RU2739561C2 (es)
WO (1) WO2018019663A1 (es)
ZA (1) ZA201900542B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
KR102789451B1 (ko) * 2019-02-01 2025-03-31 써모라이프 인터내셔널, 엘엘씨 질산염 보강 조성물 및 이의 사용 방법
WO2022104157A1 (en) 2020-11-12 2022-05-19 Thermolife International, Llc Methods of increasing blood oxygen saturation
JP2024508693A (ja) 2021-02-11 2024-02-28 サーモライフ インターナショナル， エルエルシー 一酸化窒素ガスを投与する方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157260T3 (es) * 1993-06-04 2001-08-16 Biotime Inc Solucion semejante a plasma.
US6680305B1 (en) * 1993-06-04 2004-01-20 Biotime, Inc. Physiologically acceptable aqueous solutions and methods for their use
US6940827B2 (en) * 2001-03-09 2005-09-06 Adaptix, Inc. Communication system using OFDM for one direction and DSSS for another direction
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
KR100478982B1 (ko) 2002-05-02 2005-03-25 금호석유화학 주식회사 신규 산발생제 및 이를 함유한 박막 조성물
US7498039B2 (en) * 2002-10-10 2009-03-03 Thompson Diana F Nutritional supplement containing sea water minerals
AU2004257693B8 (en) * 2003-07-09 2009-08-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7759306B2 (en) * 2006-05-16 2010-07-20 Simoni Jan S Methods of treating acute blood loss
CN105746492A (zh) 2007-02-17 2016-07-13 哈佛学院董事会 用于进行组织保存的组合物以及方法
WO2009105604A1 (en) 2008-02-20 2009-08-27 Auspex Pharmaceuticals, Inc. Substituted triazolopyridines
ES2343777B1 (es) 2009-01-14 2011-05-25 Laboratoires Quinton International S.L Procedimiento de recogida y envasado farmaceutico de agua de mar.
DE102009034132A1 (de) * 2009-07-20 2011-01-27 B. Braun Melsungen Ag Plasmaadaptierte und balancierte Gelatinelösung
RU2423987C1 (ru) * 2009-12-31 2011-07-20 Государственное образовательное учреждение высшего профессионального образования САНКТ-ПЕТЕРБУРГСКАЯ ГОСУДАРСТВЕННАЯ ХИМИКО-ФАРМАЦЕВТИЧЕСКАЯ АКАДЕМИЯ Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО СПХФА Росздрава) Инфузионный раствор для восполнения объема циркулирующей крови, восстановления водно-электролитного баланса и нормализации процессов кроветворения
EP2717879B1 (en) * 2011-06-10 2017-08-16 Queen Mary University of London Artemisinin and derivatives for use in the treatment of trauma haemorrhage
EP2817014A2 (en) * 2012-02-21 2014-12-31 Baxter International Inc Pharmaceutical composition comprising cd34+ cells
CN103989704A (zh) * 2013-02-19 2014-08-20 B.布劳恩梅尔松根股份公司 用于输液的电解质水溶液
AU2014264537B2 (en) * 2013-05-08 2018-10-18 Gambro Lundia Ab Dialysis formulation

Also Published As

Publication number Publication date
EP3490526B1 (en) 2020-05-13
WO2018019663A1 (en) 2018-02-01
RU2739561C2 (ru) 2020-12-25
ZA201900542B (en) 2022-08-31
DK3490526T3 (da) 2020-08-17
PL3490526T3 (pl) 2021-03-08
CN109789087A (zh) 2019-05-21
US20210308179A1 (en) 2021-10-07
JP2019522060A (ja) 2019-08-08
US11426427B2 (en) 2022-08-30
CA3031845A1 (en) 2018-02-01
ES2651717A1 (es) 2018-01-29
MX2019001077A (es) 2019-08-29
RU2019102162A (ru) 2020-08-26
ES2651717B1 (es) 2018-11-16
KR102404536B1 (ko) 2022-05-31
CN109789087B (zh) 2022-12-20
RU2019102162A3 (es) 2020-08-26
EP3490526A1 (en) 2019-06-05
AU2017304376A1 (en) 2019-02-14
BR112019001621A2 (pt) 2019-04-30
ES2811354T3 (es) 2021-03-11
PT3490526T (pt) 2020-08-21
KR20190039156A (ko) 2019-04-10
JP6976326B2 (ja) 2021-12-08
HUE051026T2 (hu) 2021-03-01

Similar Documents

Publication Publication Date Title
EA201992177A1 (ru) Композиции на основе нирапариба
CL2017001185S1 (es) Automovil
MX377710B (es) Anticuerpos monoclonales contra bcma.
EA201691259A1 (ru) РЕГУЛЯТОРЫ Nrf2
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
PH12016501763A1 (en) Multispecific antibodies
EA201791467A1 (ru) Водный офтальмологический раствор
MX2017003205A (es) Composiciones antimicrobianas y sus metodos de uso.
ZA201703510B (en) Antibodies, uses & methods
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
CR20200275A (es) Hidroxiisoxazolinas y derivados de estos
EA201791174A1 (ru) Антимикотическое соединение
MY186907A (en) Hair growth agent
EA201792372A1 (ru) Композиции и способы для активного наблюдения за раком предстательной железы
MX378378B (es) Solucion acuosa cristaloide isotonica
MX384131B (es) Compuestos neurotransmisores de dihidroxifenilo, composiciones y métodos.
MX391757B (es) Formulaciones de ácido 1-amino-1-ciclopropanocarboxílico.
EA202090971A1 (ru) Способы применения и композиции, содержащие дулаглутид
MX2023009431A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio.
EA201692569A1 (ru) Полимиксины с низкой степенью замещения и композиции, их содержащие
FR3058143B1 (fr) Nanocorps anti-tau
PH12017502241A1 (en) Method for stabilizing metallic mercury
PH12018501166B1 (en) Concentrated gibberellin solution formulations
CL2017000897S1 (es) Botella de perfume
PH12016502592A1 (en) 3'-substituted-abscisic acid derivatives